Delta-Sarcoglycanopathy Latest Advances
Find the Latest Research About Delta-Sarcoglycanopathy
Last Updated: 06/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Pharmacokinetic and Pharmacodynamic Evaluation of Bidridistrogene Xeboparvovec in an Aged Murine Model of Limb-Girdle Muscular Dystrophy Type 2E/R4.
Journal: Human gene therapy
Published: November 06, 2025
Muscle transcriptomics of alpha-sarcoglycanopathy highlights inflammatory pathways driving disease.
Journal: Brain : a journal of neurology
Published: June 10, 2025
Sarcoglycanopathies: From clinical diagnosis to new promising therapies.
Journal: Journal of neuromuscular diseases
Published: March 25, 2025
Detailed immune cell profiling of paediatric patient with limb girdle muscular dystrophy R3.
Journal: Journal of the neurological sciences
Published: March 16, 2025
Efficacy of Cystic Fibrosis Transmembrane Regulator Corrector C17 in Beta-Sarcoglycanopathy-Assessment of Patient's Primary Myotubes.
Journal: International journal of molecular sciences
Published: October 23, 2024
The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy.
Journal: Biochemical pharmacology
Published: October 15, 2024
Sarcospan protects against LGMD R5 via remodeling of the sarcoglycan complex composition in dystrophic mice.
Journal: The Journal of clinical investigation
Published: October 09, 2024
Sarcoglycans are enriched at the neuromuscular junction in a nerve-dependent manner.
Journal: Cell death & disease
Published: August 07, 2024
Phenotypic Variability of LGMD 2C/R5 in a Genetically Homogenous Group of Bulgarian Muslim Roma.
Journal: Genes
Published: July 30, 2024
Molecular diagnosis of Alpha-sarcoglycanopathies by NGS in seven Moroccan families and report of two novel variants.
Journal: Irish journal of medical science
Published: April 01, 2024
Last Updated: 06/24/2026